Dr. Goy on Developments in the Field of Immunology

Andre Goy, MD
Published Online: Wednesday, August 14, 2013
Andre Goy, MD, Chairman and Director and Chief of Lymphoma at John Theurer Cancer Center, comments on the recent developments in fighting cancer with the immune system.

The effort to harness the immune system to fight cancers cells has had some success, though little has translated into lasting benefit. Recently, the development of immunology has focused on unleashing T cells and promoting their antitumor effect.

Immunology research has focused, among other things, on generating chimeric antigen T cells and developing monoclonal antibodies to unleash T cells. The oncology community, Goy says, believes that using the immune system is promising and could translate into great benefit for patients.

Online CME Activities
Free CME from PER
Clinical Vignettes in Multiple Myeloma
Clinical Vignette Series: Mitigating and Managing Adverse Events in Hematology
Angiogenesis Inhibitors for Gastrointestinal Cancers: Update From the 2015 Gastrointestinal Cancers Symposium
Cancer Summaries and Commentaries™: Updates from San Francisco in Acute Myeloid Leukemia
More Reading
$auto_registration$